full comment requir non-u analyst conflict disclosur
pleas click link
valuat overli discount challeng initi outperform pt
outreach put ontrak steep revenu initi op pt
proprietari flywheel gain momentum initi outperform pt
re-tool sale renew tpm initi sector perform pt
origin on-line initi outperform
sign point revenu acceler initi sector perform pt
help provid better serv new hc consum initi sector perform pt
revenue/ebitda momentum continu build initi outperform pt
pace continu grow revenu initi outperform pt
long live eda set standard consist
model updat spend cut commod forecast
lean downturn acceler
preview incorpor new commod price lower product
easter better ship uss
model updat spend cut commod forecast
ep trend expect provis headwind stabl core
ep elev reserv build manag risk remain focu solid core
needl
market highlight mine share last week mix start week
price prior day market close estimate unless otherwis note
pursuit better outcom lower cost acceler lt hcit spend
re-affirmed dividend sourc support sector
pandem outlook updat apr
payment reform increasingli
pharmaceut look histor
port virginia idl termin
opec updat done summari
find research
insight www rbcinsightresearch com global research destin web contact capit market sale
repres access global research site
pe demand mix essenti product purchas
global commod strategi mena research
valu usd unless otherwis note
valuat overli discount challeng initi outperform pt
revenu choppi last year management work realign around
burgeon growth opportun coupl slow attrit
beyond increas confid revenu acceler also
encourag renew focu ebitda believ room
improv exist potenti enhanc earn post covid
use balanc sheet
revenu outlook improv follow step-down organ
revenu base flat look
work mitig bolu de-instal across acut care client-bas
decis made sever year ago expect headwind
attrit taper along momentum across product
commun hospit replac market increas confid revenu
re-acceler back toward msd
outsid advisor engag help improv profitability/fcf management hire
outsid firm overhaul process help formul plan drive
signific ebitda margin expans review expect take
week context ebitda margin
industri leader mean room improv
balanc sheet provid option leverag stood
well coven still avail use
 buyback management prefer accret acquisit even
settl repurchas ad turn fund buy-back would lift
ep estim
valuat overli discount challeng basi ep
trade covid-adjust estim steep
discount peer averag notabl also discount
would consid structur challeng peer
multi-year re-posit better align lt tailwind blow
pharma servic space recent biolog invest steepen lt
revenu growth trajectori lengthen runway continu ebitda margin
multi-year transform elev lt growth outlook last
sever year seri organ inorgan invest
establish manufactur leader fast-grow biolog
includ gene cell therapi market also bolster core small
molecul busi reposit power steeper sustain
combin revenu growth pathway
valu usd unless otherwis note
valu usd unless otherwis note
ebitda margin drive ebitda growth coupl continu
expect gener annual ep growth next sever year
least
primari focu remain fast-grow biolog market major
capit deploy sinc ipo center biolog
platform growth segment outpac unit
biolog vs other expect remain activ
 front management expect combin two push higher-
margin biolog revenu mix
time ipo
recent invest also bolster small molecul busi also
made signific invest earli develop platformth idea
earlier engag sponsor develop process like
carri relationship drug eventu commerci
outreach put ontrak steep revenu initi op pt
help insur identifi better manag health difficult/
costli membersthos behavior chronic medic condit
individu histor difficult engag solut
combin predict analyt human engag prove effect
earli adopt gener signific rois/sav base current
outreach pool alon revenu doubl next two year
fast-grow outreach provid visibl signific revenu
opportun effect outreach pool yoy
doesnt drive revenu give much bigger pond fish gener
revenu depend quickli ramp enrol across
contract per management gener take month launch reach
steady-st enrol waterfal analysisin studi perform
past realiti bit slower said even
project slower cadenc go forward still get
year quit mgmt still yoy growth
management expect posit steep margin expans
year invest aggress enhanc tech
platform hire new employe keep balloon outreach
pool look increas care-coach util drive
combin oper leverag
drive ebitda break-even toward time
disconnect valuat growth trajectori given larg
remain visibl growth afford balloon outreach pool
scalabl model believ trade line similarly-grow
profit digit health/hcit peer revenu pt
base estim
proprietari flywheel gain momentum initi outperform
provid data analyt solut servic -base health system
help drive improv across clinic financi administr
valu usd unless otherwis note
valu usd unless otherwis note
function sticki recur revenue/cli base provid good visibl
continu growth ebitda pace break-even earli scale
much higher
stand larg crowd space differenti
multipl way provid flexibl comprehens solut oppos
softwar long track record demonstr success creat valu
client intens focus maintain industry-lead level
client satisfact team-memb engag broad platform
address issu across clinic financi administr domain well
fee-for-servic value-bas reimburs model
sticki recur revenu base visibl growth management believ
platform gener annual organ revenu growth lt
confid target high given hcat revenu deriv
subscript recur servic contract within do
technolog base includ low-teen annual price escal steadili
ad new do still earli day
cross-sel acquir health system medic base hcat
externally-valid client satisfact well peer
track posit ebitda scale much higher oper
leverag drive margin improv anticip flat
migrat remain client azur beyond technolog
resum expand driven low-teen price escal
coupl oper leverag continu drive margin higher
notabl similar matur tech-en servic busi gener
ebitda margin
re-tool sale renew tpm initi sector perform
core cob pi busi well-align industri tailwind
continu benefit on-going ai/ml invest howev newer tpm
solut expect big growth driver slow get
traction want see evid recent re-tool sale forc build
revenue-gener pipelin get construct rate
wide moat cob provid stabl base multipl growth lever expect
three segment gener aggreg revenu
ebitda cagr next year core defens cob busi
revenu benefit continu growth medicaid spend
expand opportun medicar commerci market via accent
acquisit pi revenu growth averag low-dd driven
primarili larg remain cross-sel opportun tpm growth believ
averag hsd
re-tool sale renew tpm built total popul
management tpm platform believ could differenti leverag two
valuabl asset vast amount data churn algorithm
relationship health plan establish
dedic sale unit exist cob/pi sale forc fail gain traction
recent management comment indic invest pay offpipelin activ
give confid tpm revenu total growth acceler
low-dd
valuat fulli appreci defens defens natur
busi provid greater degre stabil tougher time
especi compar mani hcit peer said share
current trade premium group averag ep
despit expect similar lt revenu ep growth trajectori
believ fulli reflect
origin on-line initi outperform
on-line fast mme disrupt highli autom person credit provid
boast high custom satisfact level demand far outstrip mme
origin capac date addit capit lower fund cost
improv credit perform see strong growth pipelin high oper
leverag lean cost base initi outperform price
valu aud unless otherwis note
initi mme outperform rate valu proposit base
on-line credit highli autom fast approv mme well posit creat
nich person credit space see structur tailwind expect
fund drive growth mme highli competit lean fintech
cost-to-incom ratio initi outperform share pt
person credit space mme carv nich support
structur tailwind key strength busi model in-hous built
technolog platform autom applic process
mme busi model also lean compar other cost-to-
incom ratio mme track outperform prospectu expect
term origin revenu ebitda fund cash
mme eps/ocf/fcf posit
valu mme use equal weight blend dcf rel
ev/sal methodolog arriv pt support
sign point revenu acceler initi sector perform
post-pandem resumpt revenu growth next sever quarter
believ would enough take share higher howev increas
evid come acceler still lay-up book
grow multipl quarter yet drive meaning growth
revenu increas traction would encourag us construct
rate
book grow attrit stabil gener yoy
book growth six last eight quarter averag howev
time period littl progress made revenu big
part disconnect believ elev level client
attrit increas client prefer subscript oppos
licens model increas evid attrit moder
valu usd unless otherwis note
remain subscript slower burn backlog
layer revenu set stage increas stabil
growth lt
enough reignit revenu growth recent sale forc
restructur believ creat temporari airpocket book
better posit continu sell deal capit
momentum see across replac value-bas
care opportun compani expect acceler book coupl
moder attrit rang power msd/hsd revenu
growth come year
platform modern import keep ep flat
year begun work re-architect platform build micro-
servic foundat beneath applic layer expens multi-year
undertak result platform nimbl cheaper
maintain result despit expect acceler revenu
guid flat ep
help provid better serv new hc consum initi sector perform
saas-bas solut help provid better servic
empow healthcar consum larg long runway add new client
 cross-sel coupl expand sale forc enabl resum
revenu growth back end pandem happen
given larg softwar mix also put ebitda margin back
trajectori
valu usd unless otherwis note
initi sp pt lt given stabil phr client base larg
visibl nt growth expand land recent larg client
 scalabl inher margin believ trade line
similarli grow hcit peer nt pandem impact phr payment
revenu stream sale processes/pipelin consid get
construct better visibl revenu growth like
return former trajectori
posit benefit increas consumer healthcar
consum forc rise healthcar individu care option
control bigger proport hc expenditur adapt believ
doctor need get better thing attracting/retain patient
improv experi delivertr custom
improv perform collect money directli patient
platform help
manag expect expand sale help sustain lt revenu
compound-annual-growth-rate management estim ambulatori market
penetr lt remain signific opportun
add new client expand exist cross-sel continu
broaden solut set grown sale organ past
year continu hire help growth return trajectori
quickli environ normal physician practic
valu usd unless otherwis note
valu usd unless otherwis note
revenue/ebitda momentum continu build initi outperform
increas complex cost push provid seek help manag
bill collect process pure-play market continu
distanc peer via breadth capabl scale quickli
embrac new technolog long-cycl natur exist contract alon
provid management good visibl ebitda compound-annual-growth-rate target
initi outperform pt pt base trade
ebitda estim premium hcit peer believ
premium warrant given featur stabl defens earn
stream ebitda grow rate group averag next
year recent sign npr provid better visibl growth
provid look outsourc revenu cycl given increas
complex cost involv manag healthcar payment process
coupl technolog scale special vendor bring tabl
grow desir among provid outsourc revenu
cycl function notabl respond recent survey hospit
execut said plan outsourc process
next
posit benefit competit
space set apart breadth offer span
ambulatori acut post-acut environ well abil servic
fee-for-servic value-bas model innov use technolog
autom labor-intens process track-record success deploy
gener valu client inclus
tightli integr higher function referr schedul capabl management
believ combin industri tailwind competit superior
solut drive revenu ebitda growth lt
pace continu grow revenu initi outperform pt
trhc solut help mitig risk associ help lower cost
improv health combin scienc engag differenti
peer establish acceler pace market posit
continu growth also invest address sever emerg
opportun earli sign success point abl make
pace remain primari growth driver management expect growth
acceler slightli beyond gener aid
intro new program high confid continu
grow market base extent establish
trust exist pace org use solut
strengthen regulatori support programnam intro
signific white space remain cross-sel alon
penetr exist pace client would yield anoth annual
line-of-sight emerg opportun earli
encourag sign push payer pharmaci
market perform well emtm pilot help
catalyz adopt payer sinfoniarx acquisit creat easier
valu usd unless otherwis note
path payer pharmaci platform help creat much-
need altern sourc revenu oper
trade similarli grow peer combin
pace plu emerg payer opportun give signific runway
continu drive organ revenu growth proport saa
revenu grow marginsw believ bp per year
pt base trade line similarli grow saa peer
revenu estim
base learn intra-quart believ consensu estim
high conjunct note reduc estim would
point adjust ep estim street
increas loss rate provis expens assumpt
reduc estim increas target price reduc
estim reflect three chang model includ higher loss rate
assumpt correspond provis expens largest chang
overal worsen retail environ adss rel exposur
discretionari physic world retail remov share repurchas
assumpt year new rev/ep estim
prev prev prev
prev respect although reduc estim
increas target price prev adjust ep
estim discount nearest peer
oper metrics/kpis/what focus master trust data total
manag portfolio releas februari alreadi indic elev loss
rate averag vs watch earli sign
consum distress better calibr loss rate assumpt
expect outlin addit cost save strategi help off-set rise loss
setup print sinc end decemb stock
rel overal base like
aggress reserv build quarter recent loss trend master trust
deterior intra-quart retail sale believ setup print tilt
call organ growth con ep con
base channel work think estim reason
paper product feel prime pantri destock feel limit avail
keep demand averag level near-term least april look
valu usd unless otherwis note
valu usd unless otherwis note
quarter specif estim fx pt headwind sale input
cost neutral potenti slight tailwind
sale strong long march quarter iri total
dollar sale averag basi pt
acceler sequenti decemb quarter result led toilet
paper sale diaper sale adult incontin
sale facial tissu sale paper towel
sale clear portfolio experienc
lift pantri load question remain much actual get
use consum stock pile fear case draw
inventori eventu fact materi rise usag think
answer like somewher middl psycholog consum
gotten use see empti paper product shelv come across
inventori feel inclin buy even suffici amount home
fear may avail later hand think investor
underestim increas usag shelter place restrict
call shipment volum growth ep con
base channel work think estim reason much
portfolio experienc near-term benefit pantri load
like result increas hh penetr go forward make
good set long-term like result increas relianc third parti
manufactur near-term keep demand
expect shipment growth march accord iri total
retail volum sale averag basi pt
acceler sequenti dec result driven truli
twist dogfish head importantli adam
angri orchard saw meaning acceler page provid volum
bridg break shipment estim increas brand
premis assum premis sale
month march remind struggl keep demand
even covid like littl inventori rel peer
gross margin like remain pressur near-term gross margin
like come increment pressur next two quarter
compani lean third-parti manufactur keep demand
volum outsourc suspect near
current forecast gross margin
bp y/i though see downsid number truli growth rate
acceler dramat pre-covid level alreadi
understand manufactur cost risen given labor shortag
suppli chain disrupt
long live eda set standard consist
overal see littl downsid print push
impact guidanc vs street full year maintain extrem
difficult complic macro environ
valu usd unless otherwis note
valu usd unless otherwis note
take-away littl neg point regard cadenc print
guid expect due restrict
ship due restrict site access send ip cadenc
lab compani seen cancel book actual grew
showcas strength eda design tool look think
eda one area full year guidanc sustain cadenc
proven quarter set standard like difficult beat
primari bear case remain valuat like continu
market remain choppi net net revenu slip
due deliveri time busi cancel time addit
guidanc assum busi cancel futur
derisk full-year guidanc continu believ eda one best
best way play entir semiconductor industri long-term
model updat spend cut commod forecast
updat model reflect spend cut announc last week
level given current oil price believ step taken maintain
strong balanc sheet liquid posit advantag peer
due strong balanc sheet diversifi oper low base product
time exercis flexibl last week announc take
action reduc capit spend curtail product north
america suspend stock repurchas program spend
addit billion billion billion lower
initi budget oper expens guid billion
lower billion repurchas million stock
suspend remain million announc action save
billion total billion
temporari shut-in poor market condit product may
curtail mboe/d net lower mb/d gross oil
canada surmont mb/d gross oil think total
compani volum manag indic june shut-in could larger
oil price could weaken inventori becom full product shut-
in could occur intern well quit stress point
shut-in manag maintain reservoir integr
break-even point bep model show action taken reduc bep
incl dividend balanc approxim full
year bep due higher capit spend level carri
bep includ dividend assum
increas activ forecast
valu usd unless otherwis note
valu usd unless otherwis note
lean downturn acceler
continu see through-cycl core hold mid- large-cap
energi investor given disciplin approach maxim profit free cash
flow sharehold return
revis ebitda current
consensu
preview incorpor new commod price lower
report earn host confer call market close
wednesday lower estim new commod price deck
also lower refin product volum previous lower
estim given sever demand destruct vs previou
expect expect growth capital-expenditure capit alloc focal point
call
full year incorpor new crude oil
price forecast henri hub natur ga price forecast
budget assum
crude oil henri hub natur ga price estim
chang crude oil price impact dcf
mmbtu chang natur ga price impact dcf
lower refin product volum product pipelin repres
adjust segment ebitda forecast within segment repres
refin product pipelin primarili volum base back
take pay contract gasolin repres product deliveri
volum jet fuel crude oil diesel forecast year-over-
year volum declin gasolin jet fuel crude oil
diesel total segment volum declin vs
easter better ship uss
strong fundament quarter overwhelm econom
impact contain strategi challeng environ
time shine expect case today
environ compani strong cultur develop nurtur
last year see compani safe view
report ep estim consensu
rel estim first quarter perform driven significantli
higher provis credit loss increas expens partial off-set
better-than-anticip net interest incom net interest margin
adjust ep estim
respect estim reflect perform assum
sever short econom downturn follow econom recoveri
begin gradual gain momentum well yield curv
steepen slightli next month
valu usd unless otherwis note
valu usd unless otherwis note
model updat spend cut commod forecast
updat model reflect spend dividend cut announc
last week final commod price realiz new hedg new
commod price forecast chang prudent better posit
navig current macro environ lower oil break-even due
cost save initi initi hedg restructur dividend cut
target capit spend million
initi budget complet activ temporarili defer could
resum late year oil price improv estim translat
us onshor product declin entry-to-exit estim total
compani product rel flat yoy leviathan field come
realiz price settl deriv yesterday announc realiz
price cash settl deriv oil natur ga price
slightli model estim ngl slightli weaker
settl million deriv million come earli
settlement oil posit
revolv draw surpris protect futur risk billion pull
previous undrawn billion revolv unexpect proactiv revolv draw
usual occur stress compani need maxim liquid
case believ preemptiv guard current oil macro
weak persist could pressur oil ga lender cost save
reduc capit spend estim net debt-to-ebitda averag
ep trend expect provis headwind stabl
valu usd unless otherwis note
valu usd unless otherwis note
recap result fundament trend stabl
consist expect old nation begin build cecl
reserv believ credit outlook drive stock rel
peer loan mix footprint may better posit weather near term
headwind fine tune estim maintain price target
core ep consensu result impact million
charg million gain trend mostli stabl steadi
averag loan growth expect margin pressur higher mortgag revenu
expens trend driven way initi
fundament perform total loan ex-hf increas billion
report margin decreas bp sequenti lower
purchas account accret lower interest non-accru earn asset
yield declin bp deposit cost declin bp bp
estim core margin ex-accret non-accrual incom decreas
bp non-interest incom million compar million
though increas modest exclud secur gain
still strong mortgag bank drove core trend expens declin
exclud way item tax credit amort adjust
effici decreas
asset qualiti trend npa decreas million
provis higher million compar million net
charge-off increas bp bp prior quarter combin
day cecl adjust provis drove increas reserv
bp loan bp total loan
estim move ep estim
ep estim maintain price target
ep elev reserv build manag risk remain focu solid
recap earn beyond elev conserv
modest margin pressur outsid higher provis credit metric
rel stabl fine tune estim reiter sector perform
ep consensu report ep includ secur
loss neg relat client interest rate swap
includ core result result driven elev provis better
expect expens trend rel control margin compress addit
stabl credit metric beyond higher provis
fundament trend net interest incom declin sequenti
million margin declin bp sequenti eop loan increas
sequenti custom fee increas core expens decreas
sequenti effici ratio improv modestli
elev cecl driven provis drove trend credit
metric rel stabl npa increas bp loan oreo
nco decreas bp bp prior quarter reflect
adopt cecl current econom environ compani
record elev provis million includ million relat
unfund commit drove bp increas reserv loan
valu usd unless otherwis note
ratio manag provid updat stress test result indic
annual loss current portfolio peak loss
appli find manag
estim revis adjust result outlook fine-tun
ep ep price
needl
produc continu battl unpreced global oil market
condit amid pandem industri thu far respond
save case suspend dividend produc track
slash invest billion sinc
begin march estim us oil product least
million bbl/d entry-to-exit basi meanwhil temporari product shut-
in alreadi underway amid refineri run cut due collaps refin product
demand balloon storag level expect refineri util rate
fall current potenti furthera second-
posit note opec/opec decis return market manag
may provid line sight improv stock balanc time
nonetheless expect oil market condit price remain fluid
interim inflect relat demand surfac
refresh wti/brent estim consist fic updat outlook
sit vs vs
long-term equilibrium price remain unchang
market highlight mine share last week mix start week
market highlight mine share last week mix start
mine share last week commod share mix
today base metal slightli implic suppli cut
chines stimulu provid posit sentiment expect china cut
benchmark interest rate second time year help combat
impact came follow announc growth came
estim vs consensu vale nyse vale announc
reduc guidanc result friday night detail
like wont last earn start mani miner
alreadi suspend guidanc past month light shutdown
domin commod news today april near term oil
valu usd unless otherwis note
valu usd unless otherwis note
contract price fallen neg due lack storag avail
take physic deliveri fuel cost averag minesit cost copper
mine sinc see chart week copper increas last week
penni start week monday
april copper exchang inventori decreas last week net
short posit specul copper decreas contract
forecast price mine share trade discount
mackay weekli global/u pandem outlook
case diagnos global vs week ago
apr sourc jhu total death exceed global mortal rate
rise week week ago us lead world
total case case growth total death europ nearli countri
continu see deceler case growth follow initi sign
slow trend two week ago eu countri highest
case count see doubl time day continu suggest
growth near tail-end phase seen post-control phase
china signific deceler took place wk wuhan lock-
china nation call social-distanc see plateau
increment increas mortal rate european countri well
spain itali franc germani uk belgium netherland us continu
demonstr day/day new case slowing/plateau doubl time
tdoubl increas day low day mid-march
recent day end last week
payment reform increasingli empow healthcar
pursuit better outcom lower cost acceler lt hcit
long-term hcit market driver strengthen set asid st impact
pandem sale cycl implement
outlook hcit grow increasingli excit innov acceler
barrier valu creation un-digit data unsupport regul
crumbl payment reform empow healthcar consum
also chang landscap requir sophist
hcit infrastructur believ groundwork place acceler hcit
spend next year
hospit execut survey corrobor first ask hcit
budget said hcit budget said
said ask anticip chang
proport reimburs tie outcom proxi need
capabl systemscurr respond
revenu risk expect proport increas next
two year last ask project prioriti listsehr project
cite top prioriti
initi coverag stock favorit idea
bring theme trend discuss note stock select
use framework help guid ratings/rankingsth primari factor
recur revenu margin scalabl abil thrive
sector perform
pharmaceut look histor dividend trend
valu usd unless otherwis note
valu cad unless otherwis note
valu usd unless otherwis note
re-affirmed dividend sourc support sector
capit alloc set becom bigger theme earn
taken closer look current histor dividend trend within
larg cap pharma expect reaffirm current
dividend level follow late increas signal support
gener surpris nevertheless play
defens natur sector expect cut also
anticip increas earli though increas would send strong
signal even nomin theme capit alloc go big
focu particularli given neg perceiv headlin around buy back
stock current environ like leav excess capit could
deploy toward think set becom next big theme
leav downturn rel dividend outlook see ampl
support taken closer look prior financi crisi direct
crisi larg cap pharma dividend remain stabl
port virginia idl termin carload note
port virginia idl one termin begin may reflect
view port volum y/i next
month due impact port charleston also issu preliminari
guidanc fiscal year begin juli volum y/i
sharp declin contain expect persist summer month
accord journal commerc note port virginia
port charleston third fourth largest port east coast
respect expect lower volum facil affect
volum alreadi adjust estim account
deterior outlook
total class volum y/i qtd reflect lower
intermod coal motor vehicl part carload
datacent download
uk day ahead power price record low
edf may close west burton coal plant uk septemb
endesa start construct solar pv plant
john la interest israel light rail ppp
valu gbp unless otherwis note
valu usd unless otherwis note
valu usd unless otherwis note
valu usd unless otherwis note
tax break norway
tullow tlw appoint rahul dhir ceo
oil market second run cours
opec updat done
stx earn alibaba invest cloud infrastructur
ymtc schedul enter market tsmc develop track
samsung look get engin china
pe demand mix essenti product purchas
us spot ethylen trade lower decreas w/w per ihsm
us ethylen spot market activ last week pound complet
price trend lower remain weak trade complet
april deliveri may deliveri april usgc
ethylen wtd averag price decreas
us spot pe price lldpe ldpe hdpe move lower demand
resin especi flexibl packag food hygien pharma product
remain high given pandem
dd pre-announc ebitda link increas product face mask
materi help address global suppli link publish chemic
coat earn preview link pre-announc adj ebitda
link manufactur institut releas metal
shipment report highlight robust beverag growth link
earn read-through cc vntr link announc today
kent master appoint chairman ceo
opec updat done
global commod strategi mena research
opec appar crisi manag mode tri discern could
done address dramat declin crude price particularli
believ opec option embrac version seren prayer
essenti accept thing chang courag
chang thing wisdom know differ think opec
may make headway sharpen complianc messag particularli
around perenni underperform notabl russia
saudi complianc doubt think saudi arabia may amen
drop product even order assist rebalanc act
stave potenti punit measur washington presid trump
continu face call congress impos tariff import saudi
none measur arrest immedi demand destruct
storag satur problem weigh heavili particularli us
price could potenti help ensur better back half year
crisi contain
capit market busi name use certain branch subsidiari royal bank canada includ dominion secur inc
capit market llc europ limit royal bank canada hong kong branch royal bank canada sydney branch inform contain
report compil capit market sourc believ reliabl represent warranti express impli made royal
canada capit market affili person accuraci complet correct opinion estim contain
report constitut capit market judgement date report subject chang without notic provid good faith without
legal respons noth report constitut legal account tax advic individu tailor invest advic materi prepar gener
circul client prepar without regard individu financi circumst object person receiv invest
servic contain report may suitabl recommend consult independ invest advisor doubt
suitabl invest servic report offer sell solicit offer buy secur past perform guid
futur perform futur return guarante loss origin capit may occur capit market research analyst compens base
part overal profit capit market includ profit attribut invest bank revenu everi provinc canada state
 countri throughout world law regul type secur invest product may offer
resid well process result secur discuss report may elig sale jurisdict capit
market may restrict publish research report time time due regulatori restrict and/ intern complianc polici case
latest publish research report avail client may reflect recent materi chang applic industri and/or applic subject compani
capit market research report current date set forth research report report circumst
constru solicit act secur broker dealer jurisdict person compani legal permit carri busi
secur broker dealer jurisdict full extent permit law neither capit market affili person accept
liabil whatsoev direct indirect consequenti loss aris connect use report inform contain herein
matter contain document may reproduc copi mean without prior written consent capit market instanc
addit inform avail request
public approv capit market llc member finra nyse sipc regist broker-deal accept
respons report dissemin unit state recipi report regist broker-deal bank act
broker dealer capac wish inform regard effect transact secur discuss report
contact place order capit market llc
public approv dominion secur inc member iiroc canadian recipi report design institut
ontario accredit investor british columbia alberta sophist purchas quebec similar permit purchas provinc
wish inform regard effect transact secur discuss report contact place order
dominion secur inc without way limit forego accept respons report dissemin canada
public approv europ limit el author prudenti regul author regul
conduct author fca prudenti regul author connect distribut unit kingdom materi gener
distribut unit kingdom retail client defin rule fca rbcel accept respons report dissemin
unit kingdom
materi distribut germani europ limit frankfurt branch regul bundesanstalt fr finanzdienstleistungsaufsicht bafin
receiv advic australia
materi distribut australia royal bank canada sydney branch abn afsl materi prepar
gener circul take account object financi situat need recipi accordingli recipi act
materi consid appropri materi regard object financi situat need materi relat acquisit
possibl acquisit particular financi product recipi australia obtain relev disclosur document prepar respect product
